
HydraMed Review
Best for: patients wanting all-in pricing with a single intake fee
HydraMed is a nationwide telehealth platform offering compounded semaglutide, tirzepatide, and a broader peptide menu including PT-141, GHK-Cu, and NAD+ in injection, nasal, and topical forms. All-inclusive monthly pricing covers prescription and supplies, free shipping, and a quick medical questionnaire intake. Compounding is performed at a US FDA-registered pharmacy. Also offers mobile IV services in CO, FL, TN, and WY.
What the monthly price covers
Medication
Included
Provider visits
Included
Shipping
Included
Lab work
Not disclosed
Coaching
Included
No insurance needed · Vetted by our editors
WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more
The Bottom Line
HydraMed is a solid telehealth option with balanced features and pricing.
HydraMed at a glance
- Type
- GLP-1 telehealth provider
- Medications
- Semaglutide, Tirzepatide
- Starting price
- $179/mo
- Pricing model
- Scales with dose — higher doses cost more
- What's included
- Medication · Consult · Shipping · Coaching
- Availability
- 11 states
- FDA status
- No FDA warning letter on record
How we scored HydraMed
Each dimension is scored algorithmically from HydraMed’s real pricing, drugs offered, verification status, and disclosed inclusions — using the same six-dimension framework we apply to every provider.
Value25%
7.3/10At $179/mo, HydraMed runs about 6% above the $170 median for GLP-1 providers. Note the price scales with dose, so budget for higher tiers as you titrate.
Effectiveness25%
8.6/10HydraMed offers both semaglutide and tirzepatide — the two GLP-1 molecules with the strongest published weight-loss trial outcomes.
User Experience15%
7.9/10Online intake and platform experience — consult included in the price; 6 platform features disclosed.
Trust & Safety15%
8.6/10Key details fully confirmed by our editors; no FDA warning letters on file (last checked 2026-06-03).
Accessibility10%
7.0/10HydraMed is available in 11 states — confirm yours is covered.
Support10%
7.7/10Coaching/dietitian access included.
How we verified this HydraMed review
Last checked 2026-06-03- Confirmed current pricing across 3 dose/plan tiers
- Confirmed availability in 11 states
- Confirmed what the monthly price does and doesn't include
- Checked the FDA warning-letter database for enforcement actions
- Walked the public intake/checkout flow on the provider's site
Pricing, availability, and compliance facts come from the provider's own site and primary regulatory records — see the sources below. Editorial confidence in this data: high.
GLP-1 medications HydraMed offers
Tap any medication to read our plain-English guide — how it works, dosing, side effects, and what the trials found.
Pricing
Ready to get started?
Plans and promotions change often — check HydraMed's current pricing and active discounts before you decide.
What we like
- All-inclusive pricing with no add-ons
- Free shipping
- US FDA-registered compounding pharmacy
- Quick intake process
Watch-outs
- Wide peptide menu beyond GLP-1s — patients should stay focused on FDA-approved indications
- Trust score moderate pending more independent verification
HydraMed: one flat monthly price for compounded GLP-1s — if you live in the right state
HydraMed is a telehealth platform built around a simple promise: pay one all-inclusive monthly price and get your prescription, your supplies, and your shipping with nothing extra tacked on later. For compounded semaglutide it starts at $179 a month and climbs as your dose increases, which is honest in its own way — you only pay more when you actually need more medication. The catch most people miss is that HydraMed describes itself as nationwide but, by our count, only genuinely serves eleven states plus Washington, DC. If you live in one of them, it's a clean, no-surprises option. If you don't, you can stop reading here.
How the all-in pricing actually works
HydraMed uses a 'scales with dose' model. The lowest semaglutide dose comes in at $179 monthly, and the price steps up as you titrate toward a maintenance dose; compounded tirzepatide sits a tier higher again. The number you see is meant to be the number you pay — it bundles the medication itself, the medical consult, the injection supplies, and shipping. There's no separate membership fee layered on top and no surprise 'consult fee' billed the first month, which is genuinely refreshing in a market where the headline price is often only half the story.
For context, HydraMed's entry price runs a little above the category median of $170, so it isn't the cheapest door in the building. What you're paying the small premium for is the bundling and the coaching, not a rock-bottom sticker. If your only goal is the lowest possible monthly cost, a leaner cash-pay compounder will beat it. If you'd rather not get nickel-and-dimed and want everything in one line item, HydraMed's model earns its keep.
What's actually included
- Compounded semaglutide or tirzepatide, dispensed monthly
- Free telehealth phone appointments with the prescribing team
- Free shipping on every order
- Monthly check-ins with a dedicated HydraMed coach
- Injection supplies, with no add-on charges
The medications — and the peptide menu that needs a caveat
For weight loss, the two medications that matter here are compounded semaglutide and compounded tirzepatide, the same active ingredients as the brand-name GLP-1s but produced at a compounding pharmacy rather than by the original manufacturer. Compounding is performed at a US FDA-registered pharmacy, which is the baseline you want to see, though HydraMed does not publicly name a specific accredited compounding partner the way some competitors do — something to factor into your trust calculation.
Where HydraMed gets unusual is the breadth of its catalog. Beyond GLP-1s it offers a wide peptide menu — PT-141, GHK-Cu, NAD+ and others — in injection, nasal, and topical forms. That range may look like a feature, but for a weight-loss patient it's mostly noise, and some of it sits well outside FDA-approved indications. Our honest advice: if you come to HydraMed, come for the GLP-1, and don't let the menu talk you into stacking experimental peptides on top of your weight-loss plan. Keep your treatment focused on what's actually proven.
Who HydraMed is right for — and who should skip it
This is a good fit if you live in a served state, you value a single predictable bill, and you want phone access to your provider plus a coach checking in monthly rather than a faceless prescription mill. The bundled coaching and free consults make it friendlier than the bare-bones cash compounders for people who actually want some hand-holding.
Skip it if you live outside its footprint, if you're hunting for the absolute lowest price, or if you want a provider that names its accredited compounding pharmacy and has a long independent track record. HydraMed's footprint is also worth a second look on its own terms — it leans heavily on metro-area coverage within those states, and it layers in mobile IV services in Colorado, Florida, Tennessee, and Wyoming, which tells you this is as much a regional concierge-wellness brand as a pure national GLP-1 shop.
Trust, safety, and medical oversight
On the positive side, there are no FDA warning letters on file for HydraMed, and prescriptions run through a licensed telehealth provider with real phone-appointment access rather than an asynchronous-only form. The medication is compounded at a US FDA-registered facility. The honest weak spot is verification depth: HydraMed doesn't disclose a named, separately accredited compounding partner, and its independent track record is still thin, so we hold its trust rating at moderate pending more outside confirmation. That's not a red flag — it's an absence of the extra proof points the most established players publish. You can read how we weigh these factors in our scoring methodology.
Bottom line
HydraMed is a tidy, no-add-ons way to get compounded semaglutide or tirzepatide starting at $179 a month, with free shipping, free phone consults, and a real coach — provided you live in one of the eleven states (plus DC) it actually serves. It's slightly above the category median, doesn't name its compounding pharmacy, and surrounds its GLP-1s with a peptide menu you should largely ignore. Treat it as a solid regional pick for people who want everything bundled and don't mind paying a small premium for the convenience — and confirm both your state eligibility and the current dose-by-dose price directly before you sign up, since published pricing has shifted recently.
Shopping around? Sunlight ($159/month) and Bodybuilding Health+ ($179/month) are the nearest alternatives to HydraMed in our rankings.
Ready to start with HydraMed?
Starting at $179/month. See current pricing and start your free consultation.
HydraMed might not be your best fit if…
We rank editorially, so here’s where a different provider we track may serve you better.
Alternatives to HydraMed
Enhance MD
Best for: lab-monitored compounded GLP-1 with mandatory video visit
Editorial score · methodology
Editorial score · methodology
Editorial score · methodology
Frequently Asked Questions
Key terms, explained
New to GLP-1s? Tap any term for a quick, plain-English definition.
- Semaglutide · Drugs and brands
- Tirzepatide · Drugs and brands
- Compounded GLP-1 · Pharmacy and drug forms
- 503A pharmacy · Pharmacy and drug forms
- PCAB accreditation · Pharmacy and drug forms
- Prior authorization (PA) · Insurance and regulatory
- Off-label use · Insurance and regulatory
- FDA Drug Shortage List · Insurance and regulatory
Sources
The primary regulatory filings and peer-reviewed studies cited throughout this HydraMed review:
Sources & methodology — as of July 2026
- 1.Weight Loss Rankings — GLP-1 Pricing Index 2026 (our independent dataset)— WeightLossRankings.org.
- 2.FDA — Compounding and the 503A Pharmacy Framework— U.S. Food & Drug Administration.
- 3.FDA — Drug Shortages Database (current shortage listings)— U.S. Food & Drug Administration.
- 4.PCAB — Pharmacy Compounding Accreditation Board Standards— Accreditation Commission for Health Care (ACHC) / PCAB.
- 5.KFF — Medicaid coverage research (anti-obesity & GLP-1 drug policy)— Kaiser Family Foundation.
- 6.STEP 1 Trial — Once-Weekly Semaglutide in Adults with Overweight or Obesity (Wilding JPH et al.)— New England Journal of Medicine.PMID: 33567185.
- 7.FDA — Wegovy (semaglutide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 8.FDA — Ozempic (semaglutide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 9.SURMOUNT-1 Trial — Tirzepatide Once Weekly for the Treatment of Obesity (Jastreboff AM et al.)— New England Journal of Medicine.PMID: 35658024.
- 10.FDA — Zepbound (tirzepatide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 11.FDA — Mounjaro (tirzepatide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 12.SURMOUNT-5 Trial — Tirzepatide vs. Semaglutide Head-to-Head in Obesity (Garvey WT et al.)— New England Journal of Medicine.PMID: 40334173.
Ready to start with HydraMed?
Starting at $179/month. See current pricing and start your free consultation.